Articles
Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth
Mechanisms underlying CD19-positive ALL relapse after anti-CD19 CAR T cell therapy and associated strategies
Advances in targeted therapy for acute myeloid leukemia
Trends and projections of kidney cancer incidence at the global and national levels, 1990–2030: a Bayesian age-period-cohort modeling study
Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma
No hay comentarios:
Publicar un comentario